Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetails
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
By Dilip Cherian The Centre’s decision to significantly expand the Enforcement Directorate (ED) is a lot more than a routine...
Read moreDetails
The ongoing visit of Myanmar’s President Min Aung Hlaing to India is fraught with geopolitical significance. India's reputation as a...
Read moreDetails
An unwarranted observation by the Chief Justice of India Surya Kant has stirred the Indian youth out of its seeming...
Read moreDetails
Prominent Muslim voices have asked the Prime Minister of India to declare the cow a national animal and subsequently ban...
Read moreDetails
